Sanoculis: Early-Stage Glaucoma Treatment Achieves Pressure Lowering Without an Implant

article image

Eyeing the success of Glaukos Corp. and other up-and-coming companies developing minimally invasive surgeries for glaucoma, Sanoculis wants to go one step further, with a procedure that creates drainage for aqueous humor without leaving behind an implant. In creating minimal damage, the start-up hopes to offer a safe and repeatable procedure.

There’s hope for glaucoma sufferers—4.2 million people in the US and 78 million worldwide—who, without effective treatments, would progressively and irreversibly lose their eyesight.


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: